(Q54325969)

English

Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.

scientific article published in February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

author name string

Tetsuro Nariai

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Katsuya Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Masaya Mori

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Seiji Katayama

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Seiji Hori

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Kazuki Matsui

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

89

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

1-2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

44-52

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Aldosterone biosynthesis, regulation, and classical mechanism of action

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone and the heart

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone as a cardiovascular risk hormone

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone in chronic kidney and cardiac disease

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Effects of aldosterone on the vasculature

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

SM-368229, a novel selective and potent non-steroidal mineralocorticoid receptor antagonist with strong urinary Na+ excretion activity.

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone Increases NHE-1 Expression and Induces NHE-1-Dependent Hypertrophy in Neonatal Rat Ventricular Myocytes

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extracellular sodium

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Aldosterone and glomerular podocyte injury

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Beneficial impact of spironolactone in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1159%2F000335559

21 January 2018

Identifiers

10.1159/000335559

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/22302095

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54325969&oldid=932329785"